期刊文献+

基于体重的肝素负荷剂量下体重指数对活化凝血时间的影响 被引量:1

Effect of Body Mass Index on Activated Clotting Time in Patients Received Weight-Based Dosing of Unfractionated Heparin
下载PDF
导出
摘要 目的 探讨在经皮冠状动脉介入(PCI)治疗中,基于体重的肝素负荷剂量下体重指数(BMI)对全血活化凝血时间(ACT)的影响。方法前瞻性入选男性冠心病患者78例,年龄45~77(63.86±6.89)岁,以BMI为依据将患者分为4组:A组20例(15.57≤BMI〈23.03)。B组20例(23.03≤BMI〈25.35),C组18例(25.35≤BMI〈27.68),D组20例(BMI≥27.68)。所有患者给予100U/kg负荷全量肝素,并于术前、肝素负荷剂量后5min、10min、30min、60min抽血,采用Hemotec法检测ACT值,以术前ACT(ACT0)为基线,其余ACT值与其差值分别标记为△ACTs,MATLAB软件计算△ACT一时间曲线下面积。结果负荷肝素后ACT达峰时间各不相同:33.33%位于ACT5时间点,51.33%位于ACT10时间点,15.34%位于ACT30时间点,各组间差异有统计学意义(P〈0.05)。△ACT-时间曲线下面积随着BMI增大而增大,各组间差异有统计学意义(P〈0.01)。结论相对于低BMI患者,基于实际体重给予负荷量肝素对于大BMI患者是过量的。 Objective To assess the effect of body mass index (BMI) on activated clotting time (ACT) in patients received weight-based dosing of unfractionated heparin (UFH) during percutaneous coronary intervention. Methods 78 male inpatients with a coronary heart disease were divided into 4 groups according to BMI: group A (15.57≤〈BM1〈23.03, n= 20), group B (23.03≤BMI〈25.35,n=20), group C (25.35≤〈BMI〈27.68,n=18), and group D (27.68≤BMI,n=20). All patients received a bolus of 100 U / kg UFH before procedure. ACT was measured by Hemotec method before and at 5 minutes, 10 minutes, 30 minutes and 60 minutes after UFH. ACT difference between before and after UFH was marked as AACT. Area under the curve (AUC) of AACT-time was calculated by MATLAB software. Results Peak ACT achieved at 5 minutes after UFH in 33.33% patients, at 10 minutes in 51.33% patients, and at 30 minutes in 15.34% patients. The time of peak ACT was significantly different between any two groups (all P〈0.05). AUC of △ACT-time increased as BMI increased and was significantly different among the four groups(P〈0.01). Conclusion Weight-based dosing may result in UFH overdose for patients with higher BMI compared to patients with lower BMI.
出处 《心电与循环》 2012年第2期74-76,共3页 Journal of Electrocardiology and Circulation
关键词 普通肝素 活化凝血时间 体重指数 Unfractionated heparin Activated clotting time Body mass index
  • 相关文献

参考文献11

  • 1Suzette Béguin,Theo Lindhout,H.Coenraad Hemker. The mode of action of heparin in plasma[J].Thrombosis and Haemostasis,1988.457-462.
  • 2Levine G N,Bates E R,Blankenship J C. 2011 ACCF / AHA / SCAI Guideline for Percutaneous Coronary Intervention A Report of theAmerican College ofCardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Journal of the American College of Cardiology,2011.e44-e122.
  • 3LeeCH,TanE,WongHB. Impact of different Asian ethnic groups on correlation between heparin dose,activated clotting time and complications in percutaneous coronary intervention[J].International Journal of Cardiology,2008.500-502.
  • 4Riney J N,Hollands JM,Smith J R. Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients[J].Annals of Pharmacotherapy,2010.1141-1151.
  • 5Harry J,M.Lemmens,Donald P.Bernstein,Jay B.Brodsky. Estimating Blood Volume in Obese and Morbidly Obese Patients[J].Obesity Surgery,2006.773-776.
  • 6Cheymol G. Effects of obesity on pharmacokinetics:implications for drug therapy[J].Clinical Pharmacokinetics,2000.215-231.
  • 7KandrotasRJ. Heparin pharmacokinetics and pharmacodynamics[J].Clinical Pharmacokinetics,1992.359-374.
  • 8Barletta J F,De Young J L,Mc Allen K. Limitations of a standardized weight-based nomogramfor heparin dosing in patients with morbid obesity[J].SurgObesRelat Dis,2008.748-753.
  • 9Riney J N,Hollands JM,Smith J R. Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients[J].Annals of Pharmacotherapy,2010.1141-1151.
  • 10Kershaw B,White R H,Mungall D. Computer-assisted dosing of heparin:management with a pharmacy-based anticoagulation service[J].Archives of Internal Medicine,1994.1005-1011.

同被引文献17

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部